Health Care & Life Sciences » Pharmaceuticals | Auris Medical Holding AG

Auris Medical Holding AG | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
26,835.20
57,336.50
50,187.10
31,920.30
15,365.20
5,470.90
Total Accounts Receivable
82.70
91.90
184.90
213.10
165.70
243.80
Inventories
464.60
415.80
-
-
-
-
Other Current Assets
248.70
266.90
646.00
1,015.90
751.90
437.50
Total Current Assets
27,631.20
58,111.00
51,018.00
33,149.40
16,282.80
6,152.20
Net Property, Plant & Equipment
220.30
236.90
222.30
363.40
259.50
34.40
Long-Term Note Receivable
-
-
38.00
112.90
78.70
16.20
Intangible Assets
1,667.00
1,492.00
1,481.00
1,458.70
1,671.70
3,586.20
Total Assets
29,518.40
59,872.90
52,759.50
35,288.40
18,516.20
10,328.70
ST Debt & Current Portion LT Debt
15,417.10
-
-
2,177.10
4,661.00
Accounts Payable
1,063.90
3,161.30
-
-
-
Other Current Liabilities
2,142.20
1,306.10
6,160.70
6,636.20
6,037.50
Total Current Liabilities
18,623.20
4,467.30
6,160.70
8,813.30
10,698.50
Long-Term Debt
-
-
-
9,988.20
5,730.40
Provision for Risks & Charges
369.20
1,419.60
1,574.30
2,058.80
2,014.30
Deferred Taxes
368.40
329.70
327.30
193.40
183.50
Other Liabilities
-
-
-
115.30
1,884.80
Total Liabilities
19,360.80
6,249.60
8,062.20
21,373.10
20,734.90
Common Equity (Total)
10,157.60
53,623.30
44,697.20
13,915.30
2,218.80
Total Shareholders' Equity
10,157.60
53,623.30
44,697.20
13,915.30
2,218.80
Total Equity
10,157.60
53,623.30
44,697.20
13,915.30
2,218.80
Liabilities & Shareholders' Equity
29,518.40
59,872.90
52,759.50
35,288.40
18,516.20

About Auris Medical Holding

View Profile
Address
Clarendon House
Hamilton HC HM 11
Bermuda
Employees -
Website http://www.aurismedical.com
Updated 07/08/2019
Auris Medical Holding AG engages in the provision of biopharmaceutical business. It focuses on the development of novel products for the treatment of inner ear disorders. It includes tinnitus, haring loss, and meniere's disease.